Predictive Factors Shape Guselkumab Response in Psoriasis
TOPLINE:A new study found that 57.6% of patients with psoriasis achieved super responder status with guselkumab, characterised by complete skin...
TOPLINE:A new study found that 57.6% of patients with psoriasis achieved super responder status with guselkumab, characterised by complete skin...